These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 2138777)
1. Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice. Formby B; Miller N Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2438-42. PubMed ID: 2138777 [TBL] [Abstract][Full Text] [Related]
2. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line. Chosich N; Harrison LC Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738 [TBL] [Abstract][Full Text] [Related]
3. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice. Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727 [TBL] [Abstract][Full Text] [Related]
4. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells. Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255 [TBL] [Abstract][Full Text] [Related]
5. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice. Rivereau AS; You S; Lalain S; Gouin E; Saï P Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345 [TBL] [Abstract][Full Text] [Related]
6. Exclusive expression of MHC class II proteins on CD45+ cells in pancreatic islets of NOD mice. McInerney MF; Rath S; Janeway CA Diabetes; 1991 May; 40(5):648-51. PubMed ID: 1827081 [TBL] [Abstract][Full Text] [Related]
7. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Reich EP; Sherwin RS; Kanagawa O; Janeway CA Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922 [TBL] [Abstract][Full Text] [Related]
8. Rat pancreatic islet pretreatment with anti-MHC class II monoclonal antibodies and culture: in vitro MLIC test response does not predict islet allograft survival. Bretzel RG; Flesch BK; Brennenstuhl G; Greiner I; Hering BJ; Woehrle M; Federlin K Acta Diabetol; 1993; 30(1):49-56. PubMed ID: 8329731 [TBL] [Abstract][Full Text] [Related]
9. Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice. Barzaga-Gilbert E; Grass D; Lawrance SK; Peterson PA; Lacy E; Engelhard VH J Exp Med; 1992 Jun; 175(6):1707-15. PubMed ID: 1534116 [TBL] [Abstract][Full Text] [Related]
10. The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Wang Y; Pontesilli O; Gill RG; La Rosa FG; Lafferty KJ Proc Natl Acad Sci U S A; 1991 Jan; 88(2):527-31. PubMed ID: 1899142 [TBL] [Abstract][Full Text] [Related]
11. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nishimoto H; Kikutani H; Yamamura K; Kishimoto T Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response. Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513 [TBL] [Abstract][Full Text] [Related]
13. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens. Schirrmacher V; Schild HJ; Gückel B; von Hoegen P Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150 [TBL] [Abstract][Full Text] [Related]
15. IFNγ-Induced MHC Class II Expression on Islet Endothelial Cells Is an Early Marker of Insulitis but Is Not Required for Diabetogenic CD4 Scott NA; Zhao Y; Krishnamurthy B; Mannering SI; Kay TWH; Thomas HE Front Immunol; 2018; 9():2800. PubMed ID: 30555479 [TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma enhances the expression of the major histocompatibility class I antigens on mouse pancreatic beta cells. Campbell IL; Wong GH; Schrader JW; Harrison LC Diabetes; 1985 Nov; 34(11):1205-9. PubMed ID: 3930327 [TBL] [Abstract][Full Text] [Related]
17. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666 [TBL] [Abstract][Full Text] [Related]
18. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy. Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066 [TBL] [Abstract][Full Text] [Related]
19. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Noorchashm H; Noorchashm N; Kern J; Rostami SY; Barker CF; Naji A Diabetes; 1997 Jun; 46(6):941-6. PubMed ID: 9166663 [TBL] [Abstract][Full Text] [Related]
20. The presence of splenic T cells specific for islet cell antigens in nonobese diabetic mice. Nagata M; Yokono K; Hatamori N; Shii K; Baba S Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):171-80. PubMed ID: 2676272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]